pharma · Advanced Cancer · Non-small Cell Lung Cancer · RCUS
Arcus Biosciences
Arcus Biosciences clinical programs — 53 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3928 Point Eden Way, Hayward, California 94545, US
- Founded
- 2015
- Employees
- 655
- Programs
- 53
- Drugs
- 25
- Patents
- 30
Arcus Biosciences projects
53 ClinicalTrials.gov programs sponsored by Arcus Biosciences.
Arcus Biosciences has 53 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
[14C]-etrumadenant
Arcus Biosciences
Healthy Participants
1 trial -
casdatifan
Arcus Biosciences
Clear Cell Renal Cell Carcinoma
1 trial -
etrumadenant
Arcus Biosciences
GastroEsophageal Cancer
1 trial -
zanzalintinib
Arcus Biosciences
Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors
1 trial -
zimberelimab
Arcus Biosciences
Advanced Solid Tumors
1 trial
Frequently asked questions
How many clinical projects does Arcus Biosciences have?
53 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.